Encompass Health guidance above views
Encompass Health posts a strong Q4 2025 with adjusted EPS of $1.46 and revenue of $1.54B, topping forecasts, and issues solid full-year 2026 EPS guidance above Wall Street amid manageable regulatory and Medicare Advantage headwinds; shares surge.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.